Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cosmos Health Inc. - Common Stock (NQ: COSM )

0.6193 -0.0207 (-3.23%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cosmos Health Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
BestGrowthStocks.com issues New Growth Report on Cosmos Health
NEW YORK, NY / NewsDirect / September 13th, 2023 / Best Growth Stocks, a leading independent equity research and corporate access firm focused on finding and reporting on the best growth stocks... 
Via TheNewswire.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Is Nutraceuticals Player Cosmos Health Stock Trading Higher Today?
Cosmos Health Inc (NASDAQ: COSM) announced its inaugural 2026 revenue and  
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023
Via ACCESSWIRE
Cosmos Health Q2: Revenues Slip 6%, Unfavorable Forex, Positive Adjusted EBITDA & More
Cosmos Health Inc. (NASDAQ: COSM) reported 
Via Benzinga
Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04
Via ACCESSWIRE
Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor
Via ACCESSWIRE
Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain
Via ACCESSWIRE
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday saw 59 companies set new 52-week lows. 
Via Benzinga
Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million
Via ACCESSWIRE
Cosmos Health And 2 Other Penny Stocks Insiders Are Buying
The Dow Jones closed higher on Monday, recording gains for the eleventh straight session. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects.... 
Via Benzinga
Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Cosmos Health (COSM) Stock Is Nosediving
Cosmos Health Inc. (NASDAQ: COSM) shares are trading lower by 17.3% to $2.05 Thursday morning after the company priced its $5.25 million registered direct offering and concurrent private placement at... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements. 
Via Benzinga
Why Nanobiotix Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket
Gainers Lytus Technologies Holdings PTV. Ltd. (NASDAQ: LYT) shares surged 39.3% to $0.6621 in pre-market trading after gaining around 14% on Wednesday. 
Via Benzinga
Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
It's time to start off the day with a breakdown of the biggest pre-market stock movers worth watching on Thursday morning! 
Via InvestorPlace
Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase
Via ACCESSWIRE
Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements
Via ACCESSWIRE
Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Market
Via ACCESSWIRE
Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million
Via ACCESSWIRE
Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta
Via ACCESSWIRE
Cosmos Health set to join Russell Microcap Index
Via ACCESSWIRE
Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately €32M, or 70%, by the End of 2025 vs FY 2022.
Via ACCESSWIRE
Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income
Via ACCESSWIRE
Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.